Business Description
Acrux Ltd
ISIN : AU000000ACR3
Description
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.58 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.62 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -18.9 | |||||
| Beneish M-Score | -3.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 44.2 | |||||
| 3-Year EBITDA Growth Rate | 26.7 | |||||
| 3-Year EPS without NRI Growth Rate | 29.9 | |||||
| 3-Year FCF Growth Rate | 32.5 | |||||
| 3-Year Book Growth Rate | -44.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.7 | |||||
| 9-Day RSI | 28.24 | |||||
| 14-Day RSI | 29.48 | |||||
| 3-1 Month Momentum % | -25.58 | |||||
| 6-1 Month Momentum % | -50.77 | |||||
| 12-1 Month Momentum % | -44.83 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 1.92 | |||||
| Cash Ratio | 1.31 | |||||
| Days Sales Outstanding | 807.98 | |||||
| Days Payable | 21211.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -39.82 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 96.38 | |||||
| Operating Margin % | -1186.78 | |||||
| Net Margin % | -746.38 | |||||
| FCF Margin % | -550.25 | |||||
| ROE % | -145.73 | |||||
| ROA % | -62.42 | |||||
| ROIC % | -195.58 | |||||
| 3-Year ROIIC % | -1170.82 | |||||
| ROC (Joel Greenblatt) % | -560.54 | |||||
| ROCE % | -157.6 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.5 | |||||
| PB Ratio | 3.13 | |||||
| Price-to-Tangible-Book | 3.13 | |||||
| EV-to-EBIT | -0.94 | |||||
| EV-to-EBITDA | -0.99 | |||||
| EV-to-Revenue | 11.17 | |||||
| EV-to-FCF | -2.03 | |||||
| Price-to-GF-Value | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -106.38 | |||||
| FCF Yield % | -43.4 | |||||
| Forward Rate of Return (Yacktman) % | 307.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acrux Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.802 | ||
| EPS (TTM) (A$) | -0.02 | ||
| Beta | 1.34 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.48 | ||
| Volatility % | 66.29 | ||
| 14-Day RSI | 29.48 | ||
| 14-Day ATR (A$) | 0.001623 | ||
| 20-Day SMA (A$) | 0.029675 | ||
| 12-1 Month Momentum % | -44.83 | ||
| 52-Week Range (A$) | 0.024 - 0.099 | ||
| Shares Outstanding (Mil) | 406.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acrux Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acrux Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acrux Ltd Frequently Asked Questions
What is Acrux Ltd(ASX:ACR)'s stock price today?
The current price of ASX:ACR is A$0.03. The 52 week high of ASX:ACR is A$0.10 and 52 week low is A$0.02.
When is next earnings date of Acrux Ltd(ASX:ACR)?
The next earnings date of Acrux Ltd(ASX:ACR) is .
Does Acrux Ltd(ASX:ACR) pay dividends? If so, how much?
Acrux Ltd(ASX:ACR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers